Linda Van Le - Concepedia

Author

Linda Van Le

University of North Carolina at Chapel Hill

Also Known As

Gehrig, P.A., L Van Le, L. Le, L. Van Le, Linda Le, Linda Van Le

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Roswell Park Comprehensive Cancer Center University of Chicago Gynecologic Oncology Group University Hospitals of Cleveland

About

Linda Van Le is an author at University of North Carolina at Chapel Hill specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	424
2	Health Sciences	2	2	155
3	Public Health	2	2	58
4	Community Health Sciences	1	1	17
5	Health Behavior	1	1	17

Linda Van Le

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal, JAMA Oncology	2019	533
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Stephen Haskill, George A. Martin, Linda Van Le, Proceedings of the National Academy of Sciences	1991	323
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study Joan L. Walker, Mark F. Brady, Lari Wenzel, Journal of Clinical Oncology	2019	228
Phase II Trial of Weekly Single-Agent Paclitaxel in Platinum/Paclitaxel-Refractory Ovarian Cancer Maurie Markman, James B. Hall, Daniel L. Spitz, Journal of Clinical Oncology	2002	210
Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma Patricia L. Judson, Xiaping He, William G. Cance, Cancer	1999	183
TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort. Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal, Journal of Clinical Oncology Roc CohortBreast OncologyImmunologyGynecologyPathology	2018	138
Ovarian Carcinoma in an Adolescent With Transgenerational Exposure to Diethylstilbestrol Julie Blatt, Linda Van Le, Timothy M. Weiner, Journal of Pediatric Hematology/Oncology Des ExposureTumoral PathologyEndocrine-related CancerGenitourinary CancerMalignant Disease	2003	96
Evaluation of a Streamlined Oncologist-Led <i>BRCA</i> Mutation Testing and Counseling Model for Patients With Ovarian Cancer Nicoletta Colombo, Gloria S. Huang, Giovanni Scambia, Journal of Clinical Oncology	2018	95
Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status Steven J. Skates, Phuong Mai, Nora Horick, Cancer Prevention Research	2011	84
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer Debra L. Richardson, Michael W. Sill, Robert L. Coleman, JAMA Oncology	2017	74

Page 1